Primary Antibodies

  1. Schnellfilter:
  2. Zitierungen (27)
  3. Stark validiert (4)

Artikel 1 bis 20 von 40 gesamt

pro Seite
Seite:
  1. 1
  2. 2

Primärantikörper

Katalog-Nr. Wirt Iso. Klon Präs. Reakt. Anwendungen  

BETVIA allergen Bet v1 Antikörper

Enriched basophils from birch pollen were incubated with concentrations of nBetV1 inducing from 50 to 100% of the maximal histamine release in the presence or the absence of the mentioned HumAbs. The histamine releasewas expressed as a percentage of maximal histamine release. The mean and SD of three measurements are presented. A, when tested indicidually, only BAB1 inhibits the Betv1-induced histamine release. The five HumAbs were individually preincubated, at concentrations ranging from 0.4 to 1.5mg/ml with nBetv1 before challenging exposure of the basophils of two allergic patients (M.M and J.C). B, BAB 1 preincubated at 1.5mg/ml with nBetv1 inhibits the histamine release from the basophils of the four patients tested (H.L, E.B, M.M, and J.C). C, the Betv1-induced histamine release inhibition is specific and dose-dependent. nBetv1 was preincubated with successive dilutions of an anti-IL1a HumAB X3A3 (starting from 1.3mg/ml), of BAB1 (starting from 1.5mg/ml) or of amixture of BAB2 to BAB5 (starting at 0.1mg/ml for each) and then exposed to the baophils from patient J.C. Human IgG2 H.G27E9B1 Purified Pollen E, IP
0.1 mg / 600,00 €
  Dendritics SAS

BETVIA Antikörper

Enriched basophils from birch pollen were incubated with concentrations of nBetV1 inducing from 50 to 100% of the maximal histamine release in the presence or the absence of the mentioned HumAbs. The histamine releasewas expressed as a percentage of maximal histamine release. The mean and SD of three measurements are presented. A, when tested indicidually, only BAB1 inhibits the Betv1-induced histamine release. The five HumAbs were individually preincubated, at concentrations ranging from 0.4 to 1.5mg/ml with nBetv1 before challenging exposure of the basophils of two allergic patients (M.M and J.C). B, BAB 1 preincubated at 1.5mg/ml with nBetv1 inhibits the histamine release from the basophils of the four patients tested (H.L, E.B, M.M, and J.C). C, the Betv1-induced histamine release inhibition is specific and dose-dependent. nBetv1 was preincubated with successive dilutions of an anti-IL1a HumAB X3A3 (starting from 1.3mg/ml), of BAB1 (starting from 1.5mg/ml) or of amixture of BAB2 to BAB5 (starting at 0.1mg/ml for each) and then exposed to the baophils from patient J.C. Human IgG3 H.G26F6B2.06 Purified Pollen E
0.1 mg / 600,00 €
  Dendritics SAS

BETVIA Antikörper

Enriched basophils from birch pollen were incubated with concentrations of nBetV1 inducing from 50 to 100% of the maximal histamine release in the presence or the absence of the mentioned HumAbs. The histamine releasewas expressed as a percentage of maximal histamine release. The mean and SD of three measurements are presented. A, when tested indicidually, only BAB1 inhibits the Betv1-induced histamine release. The five HumAbs were individually preincubated, at concentrations ranging from 0.4 to 1.5mg/ml with nBetv1 before challenging exposure of the basophils of two allergic patients (M.M and J.C). B, BAB 1 preincubated at 1.5mg/ml with nBetv1 inhibits the histamine release from the basophils of the four patients tested (H.L, E.B, M.M, and J.C). C, the Betv1-induced histamine release inhibition is specific and dose-dependent. nBetv1 was preincubated with successive dilutions of an anti-IL1a HumAB X3A3 (starting from 1.3mg/ml), of BAB1 (starting from 1.5mg/ml) or of amixture of BAB2 to BAB5 (starting at 0.1mg/ml for each) and then exposed to the baophils from patient J.C. Human IgG4 H.G11A9F3.03 Purified Pollen E
0.1 mg / 600,00 €
  Dendritics SAS

BETVIA Antikörper

Enriched basophils from birch pollen were incubated with concentrations of nBetV1 inducing from 50 to 100% of the maximal histamine release in the presence or the absence of the mentioned HumAbs. The histamine releasewas expressed as a percentage of maximal histamine release. The mean and SD of three measurements are presented. A, when tested indicidually, only BAB1 inhibits the Betv1-induced histamine release. The five HumAbs were individually preincubated, at concentrations ranging from 0.4 to 1.5mg/ml with nBetv1 before challenging exposure of the basophils of two allergic patients (M.M and J.C). B, BAB 1 preincubated at 1.5mg/ml with nBetv1 inhibits the histamine release from the basophils of the four patients tested (H.L, E.B, M.M, and J.C). C, the Betv1-induced histamine release inhibition is specific and dose-dependent. nBetv1 was preincubated with successive dilutions of an anti-IL1a HumAB X3A3 (starting from 1.3mg/ml), of BAB1 (starting from 1.5mg/ml) or of amixture of BAB2 to BAB5 (starting at 0.1mg/ml for each) and then exposed to the baophils from patient J.C. Human IgG4 H.G28C10.01 Purified Pollen E
0.1 mg / 600,00 €
  Dendritics SAS

BETVIA Antikörper

Enriched basophils from birch pollen were incubated with concentrations of nBetV1 inducing from 50 to 100% of the maximal histamine release in the presence or the absence of the mentioned HumAbs. The histamine releasewas expressed as a percentage of maximal histamine release. The mean and SD of three measurements are presented. A, when tested indicidually, only BAB1 inhibits the Betv1-induced histamine release. The five HumAbs were individually preincubated, at concentrations ranging from 0.4 to 1.5mg/ml with nBetv1 before challenging exposure of the basophils of two allergic patients (M.M and J.C). B, BAB 1 preincubated at 1.5mg/ml with nBetv1 inhibits the histamine release from the basophils of the four patients tested (H.L, E.B, M.M, and J.C). C, the Betv1-induced histamine release inhibition is specific and dose-dependent. nBetv1 was preincubated with successive dilutions of an anti-IL1a HumAB X3A3 (starting from 1.3mg/ml), of BAB1 (starting from 1.5mg/ml) or of amixture of BAB2 to BAB5 (starting at 0.1mg/ml for each) and then exposed to the baophils from patient J.C. Human IgG1 H.G5F2A4.09 Purified Pollen E, WB
0.1 mg / 600,00 €
  Dendritics SAS

BETVIA Antikörper

Enriched basophils from birch pollen were incubated with concentrations of nBetV1 inducing from 50 to 100% of the maximal histamine release in the presence or the absence of the mentioned HumAbs. The histamine releasewas expressed as a percentage of maximal histamine release. The mean and SD of three measurements are presented. A, when tested indicidually, only BAB1 inhibits the Betv1-induced histamine release. The five HumAbs were individually preincubated, at concentrations ranging from 0.4 to 1.5mg/ml with nBetv1 before challenging exposure of the basophils of two allergic patients (M.M and J.C). B, BAB 1 preincubated at 1.5mg/ml with nBetv1 inhibits the histamine release from the basophils of the four patients tested (H.L, E.B, M.M, and J.C). C, the Betv1-induced histamine release inhibition is specific and dose-dependent. nBetv1 was preincubated with successive dilutions of an anti-IL1a HumAB X3A3 (starting from 1.3mg/ml), of BAB1 (starting from 1.5mg/ml) or of amixture of BAB2 to BAB5 (starting at 0.1mg/ml for each) and then exposed to the baophils from patient J.C. Human IgG2 H.G3A3C2.04 Purified Pollen E
0.1 mg / 600,00 €
  Dendritics SAS

CD49b / ITGA2 Antikörper

CD49b / ITGA2 Human IgG1 B4F12 Alexa Fluor 488 Hu F, ICC/IF
0.1 mg / 730,00 €
  Dendritics SAS

CD49b / ITGA2 Antikörper

CD49b / ITGA2 Human IgG1 B4F12 Alexa Fluor 647 Hu F, ICC/IF
0.1 mg / 730,00 €
  Dendritics SAS

CD49b / ITGA2 Antikörper

CD49b / ITGA2 Human IgG1 B4F12 Biotin Hu E, F
0.1 mg / 680,00 €
  Dendritics SAS

CD49b / ITGA2 Antikörper

IF staining of human platelets with B4F12 Human IgG1 B4F12 Purified Hu E, F, ICC/IF
0.1 mg / 600,00 €
  Dendritics SAS

Chikungunya Antikörper

IF staining of OPY4 - infected VERO cells Human IgG1 E04C1.02 Purified Hu ICC/IF, NEUT
1 mg / 1.130,00 €
  Dendritics SAS

Chikungunya Antikörper

IF staining of OPY4 - infected VERO cells Human IgG1 E04C1.02 Purified Hu ICC/IF, NEUT
0.1 mg / 600,00 €
  Dendritics SAS

Chikungunya virus Antikörper

Immunofluorescent staining of VERO cells with E26D9 Human IgG1 E26D9 Purified Hu ICC/IF, NEUT
1 mg / 1.130,00 €
  Dendritics SAS

Chikungunya virus Antikörper

Immunofluorescent staining of VERO cells with E26D9 Human IgG1 E26D9 Purified Hu ICC/IF, NEUT
0.1 mg / 600,00 €
  Dendritics SAS

Chikungunya virus Antikörper

Immunofluorescent staining of VERO cells with E26C4 Human IgG1 E26C4 Purified Hu ICC/IF, NEUT
1 mg / 1.130,00 €
  Dendritics SAS

Chikungunya virus Antikörper

Immunofluorescent staining of VERO cells with E26C4 Human IgG1 E26C4 Purified Hu ICC/IF, NEUT
0.1 mg / 600,00 €
  Dendritics SAS

Chimaeric Human IgE anti Nitrophenyl-hapten (NP) Antikörper

Chimaeric Human IgE anti Nitrophenyl-hapten (NP) Human IgE JW8/1 Supernatant E
2 ml / 960,00 €
  OriGene Technologies GmbH

Chimaeric Human IgG2 anti Nitrophenyl-hapten (NP) Antikörper

Chimaeric Human IgG2 anti Nitrophenyl-hapten (NP) Human IgG2 JW183 Purified Hu E
0.5 mg / 560,00 €
  OriGene Technologies GmbH

Chimaeric human IgM anti Nitrophenyl-hapten (NP) Antikörper

Chimaeric human IgM anti Nitrophenyl-hapten (NP) Human IgM THM Supernatant E
2 ml / 770,00 €
  OriGene Technologies GmbH

Dystonin Antikörper

Dystonin Human IgG1 H5E.Hy.4B Purified Hu C, ICC/IF, WB
0.1 mg / 600,00 €
  Dendritics SAS

Artikel 1 bis 20 von 40 gesamt

pro Seite
Seite:
  1. 1
  2. 2
  • LinkedIn